A New Therapeutic Approach for Treating DEPRESSION. NADH is a safe, potent, biological (natural) ANTIDEPRESSIVE Agent.
Experience with 205 Patients

Footnotes:

1. Birkmayer W., Danielcyk W., Neumayer E., Riederer P. (1972): The Balance of Biogenic Amines as Condition for Normal Behavior. J Neur Transm 33, 163-178.
2. Birkmayer W., E. Neumayer, and P. Riederer (1973): Die larvierte Depression beim alten Menschen. Symposium St. Moritz
3. Birkmayer W., Riederer P.: Neurotransmitter and menschliches Verhalten, Springer Verlag 1986
4. Birkmayer W., Riederer P.: Psycho-pathology, Vol. 19, Suppl. 1, (1987)
5. Birkmayer J.G.D., Birkmayer W., (1987): Improvement of Disability and Akinesia of Patients with Parkinson’s Disease by Intravenous Substitution. Ann Clin & Lab Sci 17, 1, 32-35.
6. Birkmayer W., Birkmayer J.G.D., Vrecko C., Paletta B., Reschenhofer E., Ott E. (1990): Nicotinamide Adenine Dinucleotide (NADH) as Medication for Parkinson’s Disease. Experience with 415 Patients. New Trends in Clin Neuropharmcol IV, 7-24.
7. Birkmayer W., Birkmayer J.G.D. (1991): The Coenzyme Nicotinamide Adenine Dinucleotide (NADH) as Biological Anti-depressive Agent. New Trends in Clinical Neuropharmacology 5, 19-25.
8. Brucke T., Sofic E., Riederer P., Gabriel E., Jellinger K., Danielcyk W. (1984). Die Bedeutung der serotonergen Raphe-Kortex-Projektion fur die Beeinflussung der B-adrenergen Neurotransmission durch Antidepressiva. Neuropsychiatr Clin 3: 249-255.
9. Bunney W.E., D.S. Janowsky, F.K. Goodwin, J.M. Davis, M.K.H. Brodie, D.L. Murphy, and T.N. Chase: Effect of L-DOPA on depression. Lancet I, 885-886 (1969).
10. Coppen A., Shaw DM., Mallerson A. (1965): Changes in 5-hydroxy-tryptophan metabolism in depression. Brit S Psychiat 111, 105.
11. Coppen A., MD (1972): Indoleamines and affective disorders. J Psychiat Res 9 163-171
12. Goodwin F.K., H.K.H. Brodie, D.L. Murphy, and W.E. Bunney: Administration of a peripheral decarboxylase inhibitor with L-DOPA to depressed patients. Lancet I, 908-911 (1970).
13. Matussek N., O. Benkert, K. Schneider, H. Otten, and H. Pohlmeier: L-DOPA plus Decarboxylase Inhibitor in Depression. Lancet II, 660-661 (1970).
14. Murphy DL (1972): Amine Precursors, Amines, and False Neurotransmitters in Depressed Patients. Amer J Psychiat 129,2
15. Nagatsu T., Levitt M., Udenfriend S. (1964). Tyrosine hydroxylase: The initial step in norepinephrine synthesis. J. Biol. Chem. 239, 2910-2917.
16. Nagatsu T., Namagucht T., Kato T. et al (1981): Biopterine in human brain and urine from controls and Parkinsonian patients: Application of a new radio-immunoassay. Clin Chim Acta 109, 305-311.
17. Nagatsu T., Tamaguchi T., Rahman K. et al. (1982). -Catecholamine-Related Enzymes and the Biopterin Cofactor in Parkinson’s Disease bstr VII Int. Symp. Parkinson’s disease, Frankfurt 1982 p.82.
18. Nichol C.A., Smith G.K., Duch D.S. (1985): Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin. Ann Rev Biochem 54, 729-764.
19. Riederer P.: In: Biologische Psychiatrie-Synopsis 86/87 (Beckmann H., Laux G., eds.), Springer Verlag, Heidelberg 1988, p.54-59
20. Schildkraut JJ, Klerman GL, Hammond R, Freud DG (1964): Excretion of 3-methoxy-4-hydroxy-mandelic-acid (VMA) in depressed patients treated with antidepressants drug. J Psychiatr Res 2, 257-266
21. Vrecko C., J.G.D. Birkmayer, J. Krainz (1992): Stimulation of Dopamine Biosynthesis in Cultured FC 12 Phaeochromocytoma Cells by the Coenzyme Nicotinamide adenine dinucleotide (NADH) J. New. Trans-Submitted for publication.
22. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised (DSM-III-R) (1987). Washington, DC, American Psychiatric Association.

• Link to the Anti-Depressive Agent Lab Data Values File. This file is very, very large.
• This Link contains LAB DATA ONLY: NADH: Anti-Depressive Lab Data

. . . go back to the library